Solazyme (SZYM +9%) soars after reporting a smaller-than-expected Q1 loss and the biofuels company says it's on track to begin commercial production by early 2014 and reach full capacity in 12-18 months - "unquestionably the first player in the algae arena to claim such a feat," praises Raymond James' Pavel Molchanov.
Solazyme (SZYM +9%) soars after reporting a smaller-than-expected Q1 loss and the biofuels...
From other sites
at CNBC.com (Mar 25, 2014)
at CNBC.com (Mar 7, 2014)
at CNBC.com (Jan 13, 2014)
at CNBC.com (Mar 7, 2013)
at CNBC.com (Jan 4, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs